News

  • Study reveals ethical risks of using AI for mental health

    As more people seek mental health advice from AI chatbots, new research suggests the systems are not yet ready and can fall short of professional psychotherapy ethics standards. Researchers from Brown University, working with mental health professionals, found repeated problematic behaviour even when the chatbots were prompted to use established psychotherapy approaches. In tests, chatbots [...]

  • Specialist Nursing Conference 2026: Excellence. Innovation. Leadership

    Neuro-disability nursing is rapidly evolving. Shifting service demands, growing complexity in neurological care, workforce pressures, and rising expectations for professional standards require specialist nurses to lead confidently, innovatively, and responsibly. On April 28, 2026, clinical leaders and specialists will convene for a national conference dedicated to the future of Neuro-disability nursing and our collective role [...]

  • Ebrains roadmap submission deadline extended

    EBRAINS has extended the EBRAINS roadmap submission deadline for its 2026-2036 digital neuroscience plan to 15 March 2026 after requests from the research community. The extension gives stakeholders a final opportunity to submit ideas that could help shape the future direction of Europe's digital neuroscience infrastructure. The roadmap, announced in November 2025, is a community-driven [...]

  • Eye tests reveal brain trauma more than a decade after concussions

    Eye movement tests may detect brain changes in military veterans more than a decade after concussion, according to new research. The study evaluated 78 military veterans, including 38 with a history of mild traumatic brain injury, often called TBI, a brain injury caused by a blow or jolt to the head, and 40 without. Participants [...]

  • FDA questions Huntington’s gene therapy data

    The US Food and Drug Administration says early trial data for a Huntington's gene therapy are not sufficient to support a marketing application. Gene therapy company uniQure said final meeting minutes from a Type A meeting with the FDA on 30 January 2026 confirmed the regulator's position on AMT-130. AMT-130 is an investigational gene therapy [...]

  • Antibiotics may aid TBI recovery, study suggests

    Short-term antibiotic treatment reduced brain inflammation after traumatic brain injury by altering gut bacteria in animal models, a recent study suggests. Two beneficial bacteria, Parasutterella excrementihominis and Lactobacillus johnsonii, were identified as drivers of cell repair and may also help regulate inflammation in other parts of the body. Researchers found that administering antibiotics [...]

  • Clee Medical secures seed funding for brain imaging

    Clee Medical has secured seed funding to advance real-time brain imaging for use in stereotactic neurosurgery. The financing will support development and clinical validation of the company’s Neuro Access platform, a minimally invasive technology designed to enable real-time visualisation of brain anatomy during surgery. Founded in October 2024 by Matt Lapinski and Abed [...]

  • Stroke projected to rise significantly in women over next 25 years

    Stroke is projected to rise significantly in women over the next 25 years, according to the American Heart Association. The rate of stroke among adult women in the US is expected to increase from 4.1 per cent in 2020 to 6.7 per cent in 2050. Obesity, diabetes and high blood pressure are fuelling broader increases [...]

  • Severe CTE clearly linked to dementia, study finds

    Severe CTE is clearly linked to dementia in people exposed to repetitive head impacts, researchers have found. Chronic traumatic encephalopathy, or CTE, is a progressive brain disorder caused by repeated head impacts. It is seen in people who play contact sports, serve in the military or are exposed to physical violence. CTE can [...]

  • Brainkind appoints Chris Askew OBE as interim CEO

    Brainkind has announced the appointment of Chris Askew as interim CEO, effective 23 March 2026. Askew brings extensive experience of leading national charities and membership organisations. His previous roles include Chief Executive of Diabetes UK, Chief Executive of Breakthrough Breast Cancer, and senior leadership positions at the Royal College of General Practitioners, and the General [...]